Maiko Matsushita

Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication

Xiao-Song Zhong, Maiko Matsushita, Jason Plotkin et al. · Molecular Therapy · 2009 · 541 citations · Full text

Life Sciences, Immunology, Oncology +17

Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts

Renier J. Brentjens, Elmer Santos, Yan Nikhamin et al. · Clinical Cancer Research · 2007 · 466 citations

Medicine, Immunology, Oncology +17

Quantitative monitoring of the <i>PRAME</i> gene for the detection of minimal residual disease in leukaemia

Maiko Matsushita, Hideyuki Ikeda, Masahiro Kizaki et al. · British Journal of Haematology · 2001 · 78 citations · Full text

Medicine, Hematology, Oncology +17

Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.

Hideyuki Ikeda, Maiko Matsushita, Quinten Waisfisz et al. · PubMed · 2003 · 56 citations

Life Sciences, Genetics, Hematology +17

Possible involvement of allogeneic antigens recognised by donor‐derived CD4⁺ cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy

Maiko Matsushita, Rie Yamazaki, Hideyuki Ikeda et al. · British Journal of Haematology · 2005 · 15 citations

Life Sciences, Hematology, Immunology +17